Adenocarcinoma of the pancreas with strong KRT5 expression in all cells.
Breast cancer of no special type with strong KRT5 expression in 100% of tumor cells.
Cervical squamous cell carcinoma with strong KRT5 immunostaining.
Cholangiocellular carcinoma of the liver with moderate to strong KRT5 expression.
Malignant mesothelioma exhibiting a strong KRT5 expression in all epitheloid cells.
Malignant mesothelioma showing KRT5 immunostaining of variable intensity in most epitheloid cells.
Poorly differentiated cervical squamous cell carcinoma with strong KRT5 immunostaining.
Poorly differentiated squamous cell carcinoma of the esophagus with strong KRT5 immunostaining.
Squamous cell carcinoma of the esophagus showing strong KRT5 immunostaining.
Squamous cell carcinoma of the lung showing strong KRT5 immunostaining.
Squamous cell carcinoma of the lung with strong KRT5 immunostaining.
Squamous cell carcinoma of the uterine cervix showing strong KRT5 immunostaining.
Strong KRT5 expression in all cells of a breast cancer of no special type (NST).
Strong KRT5 expression in all cells of a lobular breast cancer.
Strong KRT5 expression in all cells of a squamous cell carcinoma of the esophagus.
Strong KRT5 expression in all cells of a thymoma.
Strong KRT5 expression in all cells of a urothelial carcinoma of the urinary bladder.
Strong KRT5 expression in all epitheloid cells of a malignant mesothelioma.
Strong KRT5 immunostaining in a squamous cell carcinoma of the esophagus.
Strong KRT5 immunostaining in a squamous cell carcinoma of the lung.
Urothelial carcinoma of the urinary bladder with moderate intensity KRT5 immunostaining.